Bellicum Pharma’s Grossman Joins Arcus Bio as Chief Medical Officer

Xconomy San Francisco — 

William Grossman has joined Arcus Biosciences (NYSE: RCUS) as chief medical officer, the same position he held at his former company, Bellicum Pharmaceuticals (NASDAQ: BLCM). Grossman’s experience also includes positions at Genentech, AbbVie (NYSE: ABBV), and Biothera. Hayward, CA-based Arcus, which raised $120 million in its IPO last year, has several cancer drugs in early-stage clinical testing.